Effects of single oral dose administration of a hydantoin prostaglandin analogue BW 245C in man
- 1 June 1984
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 34 (23) , 2281-2286
- https://doi.org/10.1016/0024-3205(84)90218-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).British Journal of Clinical Pharmacology, 1983
- Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamoleClinical Pharmacology & Therapeutics, 1983
- Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogueProstaglandins, 1983
- The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.British Journal of Clinical Pharmacology, 1982
- Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.British Journal of Clinical Pharmacology, 1982
- Effects of intravenous infusion of prostacyclin (PGI2) in manProstaglandins, 1980
- Hydantoin prostaglandin analogues, potent and selective inhibitors of platelet aggregationJournal of the Chemical Society, Chemical Communications, 1979
- The Standardized Normal Ivy Bleeding Time and Its Prolongation by AspirinBlood, 1969
- The effects of nitrous oxide on the human auditory evoked responsePsychopharmacology, 1969
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962